Facilitating key conversations needed to drive forward the development of safe and effective innate stimulating immunotherapies, the 4th STING & TLR Targeting Therapies Summit will take place, for the first time […]

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along […]

Exploring Injectable Drug Formulations and Device Development Sponsors: Victrex Exhibitors: PHC Group  As Part of Europe’s leading Injectable conference series, the 5th annual Injectable Drug Delivery conference will assess innovations […]